Jazz Pharmaceuticals plcG50871105IE00B4Q5ZN4707/24/2025To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals pic's named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTES717837.0000000FOR717837.000000FORKalVista Pharmaceuticals, Inc.483497103US483497103210/01/2025Approval, on a non-binding advisory basis, of the compensation paid by us to our named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTES1296235.0000000FOR1296235.000000FORMedtronic plcG5960L103IE00BTN1Y11510/16/2025Approving, on an advisory basis, the Company's executive compensation;SECTION 14A SAY-ON-PAY VOTES337570.0000000FOR337570.000000FORTraws Pharma, Inc.68232V884US68232V884511/21/2025To approve, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTES136535.0000000FOR136535.000000FORTraws Pharma, Inc.68232V884US68232V884511/21/2025To approve, on a non-binding advisory basis, the frequency of holding an advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTES136535.0000000ONE YEAR136535.000000AGAINSTZymeworks Inc.98985Y108US98985Y108212/30/2025Advisory vote on the compensation of our named executive officersSECTION 14A SAY-ON-PAY VOTES1022611.0000000FOR1022611.000000FORArrowhead Pharmaceuticals, Inc.04280A100US04280A100703/19/2026Advisory Vote to Approve Executive Compensation.SECTION 14A SAY-ON-PAY VOTES697700.0000000AGAINST697700.000000AGAINSTAbbott Laboratories002824100US002824100004/24/2026Say on Pay - An Advisory Vote on the Approval of Executive CompensationSECTION 14A SAY-ON-PAY VOTES161219.0000000FOR161219.000000FORSanofi80105N105US80105N105404/29/2026Approve Compensation of Frederic Oudea, Chairman of the BoardSECTION 14A SAY-ON-PAY VOTES1400000.0000000FOR1400000.000000FORSanofi80105N105US80105N105404/29/2026Approve Compensation of Paul Hudson, CEOSECTION 14A SAY-ON-PAY VOTES1400000.0000000FOR1400000.000000FORInspire Medical Systems, Inc.457730109US457730109004/30/2026Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTES380827.0000000FOR380827.000000FORInspire Medical Systems, Inc.457730109US457730109004/30/2026Approval, on a advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTES380827.0000000ONE YEAR380827.000000FORWest Pharmaceutical Services, Inc.955306105US955306105505/04/2026Advisory vote to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTES34331.0000000FOR34331.000000FORAbivax SA00370M103US00370M103605/11/2026Approve Compensation of Sylvie Gregoire, Chairwoman of the BoardSECTION 14A SAY-ON-PAY VOTES1471926.0000000FOR1471926.000000FORAbivax SA00370M103US00370M103605/11/2026Approve Compensation of Marc de Garidel, CEOSECTION 14A SAY-ON-PAY VOTES1471926.0000000FOR1471926.000000FORSurrozen, Inc.86889P208US86889P208305/13/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTES284687.0000000AGAINST284687.000000AGAINSTSurrozen, Inc.86889P208US86889P208305/13/2026Advisory vote on the preferred frequency of the advisory vote on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTES284687.0000000ONE YEAR284687.000000FORRepligen Corporation759916109US759916109505/14/2026Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers.SECTION 14A SAY-ON-PAY VOTES305495.0000000FOR305495.000000FORNurix Therapeutics, Inc.67080M103US67080M103605/15/2026To approve, a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTES3023716.0000000FOR3023716.000000FORMacroGenics, Inc.556099109US556099109405/19/2026To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials.SECTION 14A SAY-ON-PAY VOTES280000.0000000FOR280000.000000FORPassage Bio, Inc.702712209US702712209905/19/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting.SECTION 14A SAY-ON-PAY VOTES304384.0000000FOR304384.000000FORPassage Bio, Inc.702712209US702712209905/19/2026To approve, on a non-binding advisory basis, the frequency of holding future advisory votes on named executive officer compensation.SECTION 14A SAY-ON-PAY VOTES304384.0000000ONE YEAR304384.000000FORViking Therapeutics, Inc.92686J106US92686J106005/19/2026TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.SECTION 14A SAY-ON-PAY VOTES583407.0000000AGAINST583407.000000AGAINSTGeron Corporation374163103US374163103605/20/2026To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement.SECTION 14A SAY-ON-PAY VOTES2266490.0000000FOR2266490.000000FORInsulet Corporation45784P101US45784P101205/20/2026To approve, on a non-binding, advisory basis, the compensation of certain executive officers.SECTION 14A SAY-ON-PAY VOTES35964.0000000FOR35964.000000FORVera Therapeutics, Inc.92337R101US92337R101405/21/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTES1079213.0000000FOR1079213.000000FORWaters Corporation941848103US941848103505/21/2026To approve, on a non-binding, advisory basis, the compensation of the Company's executive officers.SECTION 14A SAY-ON-PAY VOTES44408.0000000FOR44408.000000FORZimmer Biomet Holdings, Inc.98956P102US98956P102105/22/2026Approve, on a non-binding advisory basis, named executive officer compensation ("Say on Pay").SECTION 14A SAY-ON-PAY VOTES94987.0000000FOR94987.000000FORCytokinetics, Incorporated23282W605US23282W605705/27/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTES219027.0000000FOR219027.000000FORImmunocore Holdings Plc45258D105US45258D105405/27/2026To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTES1972943.0000000AGAINST1972943.000000AGAINSTNeurocrine Biosciences, Inc.64125C109US64125C109905/27/2026Advisory vote on the compensation paid to the Company's named executive officers;SECTION 14A SAY-ON-PAY VOTES983720.0000000FOR983720.000000FORREGENXBIO Inc.75901B107US75901B107005/29/2026Advisory vote on the compensation paid to the Company's executive employees.SECTION 14A SAY-ON-PAY VOTES76882.0000000FOR76882.000000FORTaysha Gene Therapies, Inc.877619106US877619106106/01/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTES12119056.0000000AGAINST12119056.000000AGAINSTTaysha Gene Therapies, Inc.877619106US877619106106/01/2026To indicate, on a non-binding advisory basis, the preferred frequency of future stockholder advisory votes on the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTES12119056.0000000ONE YEAR12119056.000000FORBioMarin Pharmaceutical Inc.09061G101US09061G101306/02/2026To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTES2620148.0000000FOR2620148.000000FORCrescent Biopharma, Inc.G2545C104KYG2545C104206/02/2026To approve, on a non-binding, advisory basis, the compensation of Crescent Biopharma, Inc. 's named executive officers.SECTION 14A SAY-ON-PAY VOTES104136.0000000FOR104136.000000FORCrescent Biopharma, Inc.G2545C104KYG2545C104206/02/2026To vote, on a non-binding advisory basis, on the frequency of future advisory votes to approve compensation for Crescent Biopharma, Inc.'s named executive officers.SECTION 14A SAY-ON-PAY VOTES104136.0000000ONE YEAR104136.000000FORXenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To approve, on an advisory basis, the compensation of the Corporation's named executive officers;SECTION 14A SAY-ON-PAY VOTES639900.0000000FOR639900.000000FORXenon Pharmaceuticals Inc.98420N105CA98420N105006/02/2026To approve, on an advisory basis, the frequency of future shareholder advisory votes to approve the compensation of the Corporation's named executive officers;SECTION 14A SAY-ON-PAY VOTES639900.0000000ONE YEAR639900.000000FORDenali Therapeutics Inc.24823R105US24823R105906/03/2026Advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTES846762.0000000FOR846762.000000FORGlobus Medical, Inc.379577208US379577208206/03/2026Approval, on a non-binding, advisory basis, of the 2025 compensation of the company's named executive officers (the "Say-on-Pay" Vote).SECTION 14A SAY-ON-PAY VOTES225713.0000000FOR225713.000000FORNovoCure LimitedG6674U108JE00BYSS4X4806/03/2026A non-binding advisory vote to approve executive compensation.SECTION 14A SAY-ON-PAY VOTES160324.0000000FOR160324.000000FORTrevi Therapeutics, Inc.89532M101US89532M101806/03/2026Approval, on an advisory basis, of the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTES1113973.0000000FOR1113973.000000FORMyriad Genetics, Inc.62855J104US62855J104306/04/2026To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTES1309148.0000000FOR1309148.000000FORNektar Therapeutics640268306US640268306306/04/2026To approve a non-binding advisory resolution regarding our executive compensation (a "say-on-pay" vote).SECTION 14A SAY-ON-PAY VOTES257418.0000000FOR257418.000000FORSavara Inc.805111101US805111101606/04/2026To approve, on an advisory basis, the compensation of our named executives.SECTION 14A SAY-ON-PAY VOTES1336558.0000000FOR1336558.000000FORScholar Rock Holding Corporation80706P103US80706P103006/04/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTES567450.0000000AGAINST567450.000000AGAINSTDyne Therapeutics, Inc.26818M108US26818M108006/05/2026To vote, on an advisory basis, to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTES2416199.0000000FOR2416199.000000FORTectonic Therapeutic, Inc.878972108US878972108606/08/2026Advisory approval of the compensation of the Company's Named Executive Officers.SECTION 14A SAY-ON-PAY VOTES140032.0000000FOR140032.000000FORApogee Therapeutics, Inc.03770N101US03770N101906/09/2026Approval, on a non-binding advisory basis, of the compensation of our named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTES668829.0000000FOR668829.000000FORBiogen Inc.09062X103US09062X103706/09/2026Say on Pay - To hold an advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTES61270.0000000FOR61270.000000FORCogent Biosciences, Inc.19240Q201US19240Q201206/09/2026Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTES1523381.0000000FOR1523381.000000FOREnliven Therapeutics, Inc.29337E102US29337E102906/09/2026To approve, in an advisory (non-binding) vote, the compensation of our named executive officers as disclosed in our proxy statement.SECTION 14A SAY-ON-PAY VOTES2356333.0000000FOR2356333.000000FOREnliven Therapeutics, Inc.29337E102US29337E102906/09/2026To approve, in an advisory (non-binding) vote, the frequency of future stockholder advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTES2356333.0000000ONE YEAR2356333.000000FORVoyager Therapeutics, Inc.92915B106US92915B106106/09/2026To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTES2179004.0000000FOR2179004.000000FORPalisade Bio, Inc.696389402US696389402606/10/2026To approve, on a non-binding advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTES1455519.0000000AGAINST1455519.000000AGAINSTSolid Biosciences Inc.83422E204US83422E204606/10/2026The approval of an advisory vote on executive compensation.SECTION 14A SAY-ON-PAY VOTES2505604.0000000AGAINST2505604.000000AGAINSTuniQure N.V.N90064101NL001069665406/10/2026Approval, on an advisory basis, of the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTES456693.0000000FOR456693.000000FORuniQure N.V.N90064101NL001069665406/10/2026Approval, on an advisory basis, of the frequency of advisory votes on the compensation of the named executive officers of the Company.SECTION 14A SAY-ON-PAY VOTES456693.0000000ONE YEAR456693.000000FORVeracyte, Inc.92337F107US92337F107506/10/2026The approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in our proxy statement.SECTION 14A SAY-ON-PAY VOTES64570.0000000FOR64570.000000FORBioCryst Pharmaceuticals, Inc.09058V103US09058V103506/11/2026To hold a non-binding, advisory vote regarding executive compensation.SECTION 14A SAY-ON-PAY VOTES4158394.0000000AGAINST4158394.000000AGAINSTAprea Therapeutics, Inc.03836J201US03836J201506/16/2026To approve, by non-binding advisory vote, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTES293943.0000000FOR293943.000000FORAprea Therapeutics, Inc.03836J201US03836J201506/16/2026To approve, by non-binding advisory vote, the frequency of future votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTES293943.0000000ONE YEAR293943.000000FORNuvalent, Inc.670703107US670703107506/16/2026To approve, on an advisory basis, the compensation paid to our named executive officers.SECTION 14A SAY-ON-PAY VOTES193681.0000000FOR193681.000000FORDamora Therapeutics, Inc.G2646Y104KYG2646Y104406/17/2026To approve, on an advisory basis, the compensation of the Company's named executive officers;SECTION 14A SAY-ON-PAY VOTES570081.0000000FOR570081.000000FORDamora Therapeutics, Inc.G2646Y104KYG2646Y104406/17/2026To conduct an advisory vote to determine the frequency of future advisory votes on the compensation of the Company's named executive officers;SECTION 14A SAY-ON-PAY VOTES570081.0000000ONE YEAR570081.000000FOROlema Pharmaceuticals, Inc.68062P106US68062P106606/17/2026Approval, on an advisory basis, of the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTES249041.0000000FOR249041.000000FORProtagonist Therapeutics, Inc.74366E102US74366E102906/17/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTES165972.0000000FOR165972.000000FORDisc Medicine, Inc.254604101US254604101106/18/2026To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTES491110.0000000FOR491110.000000FORGeneDx Holdings Corp.81663L200US81663L200706/18/2026Approval, on a non-binding advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTES226968.0000000FOR226968.000000FORGeneDx Holdings Corp.81663L200US81663L200706/18/2026Indicate, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two, or three years.SECTION 14A SAY-ON-PAY VOTES226968.0000000ONE YEAR226968.000000FORRevolution Medicines, Inc.76155X100US76155X100006/18/2026To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay").SECTION 14A SAY-ON-PAY VOTES1231298.0000000FOR1231298.000000FORMonopar Therapeutics Inc.61023L207US61023L207906/22/2026To approve the compensation of our named executive officers on an advisory, non-binding basis.SECTION 14A SAY-ON-PAY VOTES30472.0000000AGAINST30472.000000AGAINSTUroGen Pharma Ltd.M96088105IL001140714006/22/2026To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's proxy statement for the Annual Meeting.SECTION 14A SAY-ON-PAY VOTES115813.0000000FOR115813.000000FORArvinas, Inc.04335A105US04335A105106/24/2026To approve, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTES438076.0000000FOR438076.000000FORFulcrum Therapeutics, Inc.359616109US359616109706/24/2026A non-binding advisory vote to approve the compensation of our named executive officers;SECTION 14A SAY-ON-PAY VOTES725246.0000000FOR725246.000000FORCelldex Therapeutics, Inc.15117B202US15117B202506/25/2026To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTES465294.0000000FOR465294.000000FORTarsus Pharmaceuticals, Inc.87650L103US87650L103506/25/2026To hold an advisory vote to approve, on a non-binding basis, our named executive officer compensation.SECTION 14A SAY-ON-PAY VOTES181053.0000000FOR181053.000000FORUnited Therapeutics Corporation91307C102US91307C102706/26/2026Advisory resolution to approve executive compensation.SECTION 14A SAY-ON-PAY VOTES147003.0000000FOR147003.000000FOR